secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2026-08-31T20:35:08+00:00
Accession:  0001477449-26-000044
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc names Michael Grasher CFO; base salary $550K, $500K sign-on bonus
-------------------------------------------------------------------------

- Michael Grasher appointed CFO effective Aug 31, 2026; prior CFO of IFG Companies, Fortegra, AMERISAFE.
- Compensation: $550K base salary, $500K sign-on bonus, 85% target bonus from 2027.
- New-hire equity award ~$3M under 2023 Inducement Plan (50% RSUs, 50% PSUs) expected Sept 1, 2026.
- Charles Divita, III continues as CEO; Grasher brings 12+ years CFO experience and public markets background.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744926000044/0001477449-26-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744926000044/tdoc-20260827.htm
  HTML page:      https://secwatch.observer/filing/0001477449-26-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer